ClinConnect ClinConnect Logo
Search / Trial NCT01040923

Comparison of Digital Electronic Stethoscope to Computed Tomography (CT) Angiography in Detection of Coronary Artery Disease

Launched by SONOMEDICA, INC. · Dec 29, 2009

Trial Information

Current as of June 13, 2025

Completed

Keywords

Cad Diagnostic

ClinConnect Summary

The CardioSond is a completely noninvasive medical device which detects heart sounds and murmurs using ultrasensitive acoustic technology. The CardioSond produces a flow micro bruit score which is used to determine the likelihood of coronary artery disease.

The CardioSond exam will be given to patients who agree to participate in the study upon signing of an informed consent form and prior to the administration of beta blocker agents and / or vasodilators as part of the normal cardiac CT angiography protocol.

CardioSond data will be sent to an independent acoustic core lab which will dete...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects who are undergoing routine screening coronary CT angiography
  • Willingness to sign informed consent form
  • Exclusion Criteria:
  • Inability to provide informed consent form
  • Age less than 21 years
  • Any contraindications to coronary CT angiography
  • Known atherosclerotic heart disease, including a history of prior myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft surgery or an established diagnosis of CAD by prior X-ray or CT angiography
  • Supraventricular or ventricular arrhythmias that would be expected to affect CT-angiography image quality (e.g., atrial fibrillation, atrial flutter, ventricular tachycardia, bigeminy, and trigeminy). Patients with isolated premature atrial contractions and premature ventricular contractions may enroll.
  • Use of intravenous vasodilators
  • Any pulmonary conditions that would create abnormal physical findings that would interfere with the fidelity of the cardiac sound recording (e.g., obstructive pulmonary disease, such as asthma or COPD, with audible wheezing).
  • Presence of audible aortic or pulmonic diastolic murmurs, tricuspid or mitral flow diastolic murmurs, or continuous murmurs

About Sonomedica, Inc.

Sonomedica, Inc. is a pioneering clinical trial sponsor dedicated to advancing medical innovation through the development and commercialization of cutting-edge diagnostic and therapeutic solutions. With a strong emphasis on enhancing patient outcomes, Sonomedica leverages state-of-the-art technology and rigorous scientific methodologies to design and implement clinical trials that address unmet medical needs. The company's commitment to ethical practices and collaboration with healthcare professionals ensures the highest standards of quality and integrity in its research initiatives, positioning Sonomedica as a leader in the field of medical advancements.

Locations

Manhasset, New York, United States

Patients applied

0 patients applied

Trial Officials

Amgad N Makaryus, MD

Principal Investigator

North Shore University Hospital

Diane Dellilune, RN

Study Director

North Shore University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials